Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure

被引:81
作者
Domenighetti, AA
Wang, Q
Egger, M
Richards, SM
Pedrazzini, T
Delbridge, LMD [1 ]
机构
[1] Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia
[2] Univ Lausanne, Sch Med, Dept Med, CH-1015 Lausanne, Switzerland
[3] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland
[4] Univ Tasmania, Div Biochem, Hobart, Tas 7001, Australia
关键词
aging; cardiac function; heart failure; hypertrophy; myocytes; renin-angiotensin system;
D O I
10.1161/01.HYP.0000173069.53699.d9
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
Chronic elevation of plasma angiotensin II (Ang II) is detrimental to the heart. In addition to its hemodynamic effects, Ang II exerts cardiotrophic actions that contribute to cardiomyocyte remodeling. However, it remains to be clarified whether these direct actions of Ang II are sufficient to cause contractile dysfunction and heart failure in the absence of altered hemodynamic conditions. In this study, we used TG1306/1R (TG) mice that develop Ang II - mediated cardiac hypertrophy in absence of elevated blood pressure to investigate the phenotypic changes in cardiomyocytes during the adaptive response to chronic cardiac-specific endogenous Ang II stimulation. A 94-week longitudinal study demonstrated that TG mice develop dilated cardiomyopathy with aging and exhibit a significant increase in mortality compared with wild-type (WT) mice. Cardiac hypertrophy in TG mice is associated with cardiomyocyte hypertrophy ( 15 to 20 weeks: length + 20%; 35 to 40 weeks: length + 10%, width + 15%) but not collagen deposition. In vivo analysis of cardiac function revealed age-dependent systolic and diastolic dysfunction in TG mice ( approximate to 45% reduction in dP/dt(max) and dP/dt(min) at 50 to 60 weeks of age compared with WT). Analysis of isolated cardiomyocyte isotonic shortening showed impaired contractility in TG cardiomyocytes (30% to 40% decrease in rates of shortening and lengthening). In TG hearts, chronic Ang II exposure induced downregulation of the sarcoplasmic reticulum calcium pump (SERCA2) and diminution of Ca2+ transients, indicative of an underlying disturbance in calcium homeostasis. In conclusion, chronic Ang II myocardial stimulation without hemodynamic overload is sufficient to produce cardiomyocyte and cardiac dysfunction culminating in heart failure.
引用
收藏
页码:426 / 432
页数:7
相关论文
共 31 条
[1]
Bers D.M., 2001, Excitation-Contraction Coupling and Cardiac Contractile Force, V2th
[2]
Bohm M, 1996, MOL CELL BIOCHEM, V164, P217
[3]
Pressure-independent cardiac effects of angiotensin II in pigs [J].
Broomé, M ;
Haney, M ;
Häggmark, S ;
Johansson, G ;
Åneman, A ;
Biber, B .
ACTA PHYSIOLOGICA SCANDINAVICA, 2004, 182 (02) :111-119
[4]
ALTERATIONS IN ANG-II RESPONSIVENESS IN LEFT AND RIGHT MYOCARDIUM AFTER INFARCTION-INDUCED HEART-FAILURE IN RATS [J].
CAPASSO, JM ;
LI, P ;
ZHANG, X ;
MEGGS, LG ;
ANVERSA, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (06) :H2056-H2067
[5]
COLLAGEN IN NORMAL AND HYPERTROPHIED HUMAN VENTRICLE [J].
CASPARI, PG ;
NEWCOMB, M ;
GIBSON, K ;
HARRIS, P .
CARDIOVASCULAR RESEARCH, 1977, 11 (06) :554-558
[6]
Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure [J].
Cheng, CP ;
Suzuki, M ;
Ohte, N ;
Ohno, M ;
Wang, ZM ;
Little, WC .
CIRCULATION RESEARCH, 1996, 78 (05) :880-892
[7]
Angiotensin II stimulates α-skeletal actin expression in cadiomyocytes in vitro and in vivo in the absence of hypertension [J].
Clément, S ;
Pellieux, C ;
Chaponnier, C ;
Pedrazzini, T ;
Gabbiani, G .
DIFFERENTIATION, 2001, 69 (01) :66-74
[8]
Transgenic G alpha q overexpression induces cardiac contractile failure in mice [J].
DAngelo, DD ;
Sakata, Y ;
Lorenz, JN ;
Boivin, GP ;
Walsh, RA ;
Liggett, SB ;
Dorn, GW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8121-8126
[9]
EFFECTS OF ENDOTHELIN-1 ON THE CONTRACTILITY OF CARDIOMYOCYTES FROM THE SPONTANEOUSLY HYPERTENSIVE RAT [J].
DELBRIDGE, LM ;
MORGAN, TO ;
HARRIS, PJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (10) :755-762
[10]
DOMENIGHETTI AA, 2004, J MOL CELL CARDIOL, P37